Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous longitudinal regression equations for pulmonary function measures.

D L Sherrill1, M D Lebowitz, R J Knudson

  • 1Division of Respiratory Sciences (Westend Research Laboratories), University of Arizona, College of Medicine, Tucson 85724.

The European Respiratory Journal
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up.

Pulmonology·2022
Same author

Trust in scientific information mediates associations between conservatism and coronavirus responses in the U.S., but few other nations.

Scientific reports·2022
Same author

Pulmonary disease.

Postgraduate medicine·2016
Same author

Prospective audit of cross-sectional imaging and radiation exposure in general surgical patients.

Annals of the Royal College of Surgeons of England·2010
Same author

Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk.

Thorax·2009
Same author

Definition, epidemiology and natural history of COPD.

The European respiratory journal·2007
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Maximal expiratory flow-volume (MEFV) measures show rapid development in youth, followed by a plateau and then decline in adulthood. Lung function changes differ between sexes and flow measures versus volume measures.

Area of Science:

  • Pulmonary Physiology
  • Longitudinal Aging Studies
  • Biostatistics

Background:

  • Understanding lung function changes over the lifespan is crucial for identifying normal aging patterns and potential disease markers.
  • Previous studies often relied on cross-sectional data, limiting insights into individual lung function trajectories.
  • Longitudinal data allows for a more accurate description of developmental and decline phases in respiratory health.

Purpose of the Study:

  • To describe the age-related development and decline of maximal expiratory flow-volume (MEFV) measures using longitudinal data.
  • To compare these trajectories between sexes and with existing cross-sectional findings.
  • To identify specific age intervals for distinct phases of lung function change.

Main Methods:

Related Experiment Videos

  • Analysis of data from 930 healthy, nonsmoking adults in the Tucson Longitudinal Population Study (1972-1988).
  • Utilized statistical methods for continuous piecewise linear regression with repeated, unequally spaced measures.
  • Estimated age intervals for linear segments of MEFV indices, comparing results between sexes.
  • Main Results:

    • All MEFV measures exhibit accelerated development during the adolescent growth spurt.
    • A plateau phase of approximately 10 years for FEV1 and FVC in males is followed by a consistent decline.
    • Flow measures lacked a distinct plateau but showed later-life increases in decline rates, differing from volume measures.

    Conclusions:

    • Lung function (MEFV measures) follows distinct developmental, plateau, and decline phases influenced by age and sex.
    • Longitudinal analysis reveals nuanced patterns in lung function changes, particularly the absence of a plateau in flow measures.
    • Findings provide a detailed, age-specific reference for healthy lung function development and decline over the adult lifespan.